Industry Research Reports

Home > Reports > Chemical & Material > Global Long-acting Polypeptide Fatty Acid Side Chain Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Long-acting Polypeptide Fatty Acid Side Chain Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-08-05

Pages: 113 Pages

Report ld: 4869366

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Long-acting Polypeptide Fatty Acid Side Chain market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Long-acting polypeptide fatty acid side chains are a technology that extends the half-life of polypeptide molecules in the body by introducing fatty acid side chains into them. By binding to polypeptides, fatty acid side chains can increase their affinity with plasma proteins (such as albumin), reduce renal clearance, and thus prolong the existence time of polypeptides in the blood. This modification technology is widely used in the development of long-acting drugs, such as polypeptide drugs for the treatment of chronic diseases such as diabetes and obesity, to reduce the frequency of medication and improve patient compliance and treatment effects.

From a downstream perspective, Liraglutide accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Long-acting Polypeptide Fatty Acid Side Chain leading manufacturers including Pukang Biotechnology Technology, Changsha Morning Shine, SINOPEG, JenKem Technology, Sichuan Tongsheng Biopharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Pukang Biotechnology Technology leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Long-acting Polypeptide Fatty Acid Side Chain market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Pukang Biotechnology Technology
Changsha Morning Shine
SINOPEG
JenKem Technology
Sichuan Tongsheng Biopharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Laboratory Grade
GMP Grade

Segment by Application

Liraglutide
Semaglutide
Telportide
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Long-acting Polypeptide Fatty Acid Side Chain study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Long-acting Polypeptide Fatty Acid Side Chain: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Long-acting Polypeptide Fatty Acid Side Chain Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Laboratory Grade

1.2.3 GMP Grade

1.3 Market Segmentation by Application

1.3.1 Global Long-acting Polypeptide Fatty Acid Side Chain Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Liraglutide

1.3.3 Semaglutide

1.3.4 Telportide

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Long-acting Polypeptide Fatty Acid Side Chain Revenue Estimates and Forecasts 2020-2031

2.2 Global Long-acting Polypeptide Fatty Acid Side Chain Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Long-acting Polypeptide Fatty Acid Side Chain Sales Estimates and Forecasts 2020-2031

2.4 Global Long-acting Polypeptide Fatty Acid Side Chain Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Long-acting Polypeptide Fatty Acid Side Chain Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global Long-acting Polypeptide Fatty Acid Side Chain Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Long-acting Polypeptide Fatty Acid Side Chain Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Laboratory Grade Market Size by Manufacturers

4.5.2 GMP Grade Market Size by Manufacturers

4.6 Global Long-acting Polypeptide Fatty Acid Side Chain Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Long-acting Polypeptide Fatty Acid Side Chain Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Long-acting Polypeptide Fatty Acid Side Chain Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Long-acting Polypeptide Fatty Acid Side Chain Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Long-acting Polypeptide Fatty Acid Side Chain Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Long-acting Polypeptide Fatty Acid Side Chain Sales and Revenue by Type (2020-2031)

7.4 North America Long-acting Polypeptide Fatty Acid Side Chain Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Long-acting Polypeptide Fatty Acid Side Chain Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Long-acting Polypeptide Fatty Acid Side Chain Sales and Revenue by Type (2020-2031)

8.4 Europe Long-acting Polypeptide Fatty Acid Side Chain Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Long-acting Polypeptide Fatty Acid Side Chain Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Long-acting Polypeptide Fatty Acid Side Chain Sales and Revenue by Type (2020-2031)

10.4 Central and South America Long-acting Polypeptide Fatty Acid Side Chain Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Long-acting Polypeptide Fatty Acid Side Chain Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Long-acting Polypeptide Fatty Acid Side Chain Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Long-acting Polypeptide Fatty Acid Side Chain Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Long-acting Polypeptide Fatty Acid Side Chain Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Pukang Biotechnology Technology

12.1.1 Pukang Biotechnology Technology Corporation Information

12.1.2 Pukang Biotechnology Technology Business Overview

12.1.3 Pukang Biotechnology Technology Long-acting Polypeptide Fatty Acid Side Chain Product Models, Descriptions and Specifications

12.1.4 Pukang Biotechnology Technology Long-acting Polypeptide Fatty Acid Side Chain Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Pukang Biotechnology Technology Long-acting Polypeptide Fatty Acid Side Chain Sales by Product in 2024

12.1.6 Pukang Biotechnology Technology Long-acting Polypeptide Fatty Acid Side Chain Sales by Application in 2024

12.1.7 Pukang Biotechnology Technology Long-acting Polypeptide Fatty Acid Side Chain Sales by Geographic Area in 2024

12.1.8 Pukang Biotechnology Technology Long-acting Polypeptide Fatty Acid Side Chain SWOT Analysis

12.1.9 Pukang Biotechnology Technology Recent Developments

12.2 Changsha Morning Shine

12.2.1 Changsha Morning Shine Corporation Information

12.2.2 Changsha Morning Shine Business Overview

12.2.3 Changsha Morning Shine Long-acting Polypeptide Fatty Acid Side Chain Product Models, Descriptions and Specifications

12.2.4 Changsha Morning Shine Long-acting Polypeptide Fatty Acid Side Chain Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Changsha Morning Shine Long-acting Polypeptide Fatty Acid Side Chain Sales by Product in 2024

12.2.6 Changsha Morning Shine Long-acting Polypeptide Fatty Acid Side Chain Sales by Application in 2024

12.2.7 Changsha Morning Shine Long-acting Polypeptide Fatty Acid Side Chain Sales by Geographic Area in 2024

12.2.8 Changsha Morning Shine Long-acting Polypeptide Fatty Acid Side Chain SWOT Analysis

12.2.9 Changsha Morning Shine Recent Developments

12.3 SINOPEG

12.3.1 SINOPEG Corporation Information

12.3.2 SINOPEG Business Overview

12.3.3 SINOPEG Long-acting Polypeptide Fatty Acid Side Chain Product Models, Descriptions and Specifications

12.3.4 SINOPEG Long-acting Polypeptide Fatty Acid Side Chain Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 SINOPEG Long-acting Polypeptide Fatty Acid Side Chain Sales by Product in 2024

12.3.6 SINOPEG Long-acting Polypeptide Fatty Acid Side Chain Sales by Application in 2024

12.3.7 SINOPEG Long-acting Polypeptide Fatty Acid Side Chain Sales by Geographic Area in 2024

12.3.8 SINOPEG Long-acting Polypeptide Fatty Acid Side Chain SWOT Analysis

12.3.9 SINOPEG Recent Developments

12.4 JenKem Technology

12.4.1 JenKem Technology Corporation Information

12.4.2 JenKem Technology Business Overview

12.4.3 JenKem Technology Long-acting Polypeptide Fatty Acid Side Chain Product Models, Descriptions and Specifications

12.4.4 JenKem Technology Long-acting Polypeptide Fatty Acid Side Chain Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 JenKem Technology Long-acting Polypeptide Fatty Acid Side Chain Sales by Product in 2024

12.4.6 JenKem Technology Long-acting Polypeptide Fatty Acid Side Chain Sales by Application in 2024

12.4.7 JenKem Technology Long-acting Polypeptide Fatty Acid Side Chain Sales by Geographic Area in 2024

12.4.8 JenKem Technology Long-acting Polypeptide Fatty Acid Side Chain SWOT Analysis

12.4.9 JenKem Technology Recent Developments

12.5 Sichuan Tongsheng Biopharmaceutical

12.5.1 Sichuan Tongsheng Biopharmaceutical Corporation Information

12.5.2 Sichuan Tongsheng Biopharmaceutical Business Overview

12.5.3 Sichuan Tongsheng Biopharmaceutical Long-acting Polypeptide Fatty Acid Side Chain Product Models, Descriptions and Specifications

12.5.4 Sichuan Tongsheng Biopharmaceutical Long-acting Polypeptide Fatty Acid Side Chain Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Sichuan Tongsheng Biopharmaceutical Long-acting Polypeptide Fatty Acid Side Chain Sales by Product in 2024

12.5.6 Sichuan Tongsheng Biopharmaceutical Long-acting Polypeptide Fatty Acid Side Chain Sales by Application in 2024

12.5.7 Sichuan Tongsheng Biopharmaceutical Long-acting Polypeptide Fatty Acid Side Chain Sales by Geographic Area in 2024

12.5.8 Sichuan Tongsheng Biopharmaceutical Long-acting Polypeptide Fatty Acid Side Chain SWOT Analysis

12.5.9 Sichuan Tongsheng Biopharmaceutical Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Long-acting Polypeptide Fatty Acid Side Chain Industry Chain

13.2 Long-acting Polypeptide Fatty Acid Side Chain Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Long-acting Polypeptide Fatty Acid Side Chain Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Long-acting Polypeptide Fatty Acid Side Chain Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Long-acting Polypeptide Fatty Acid Side Chain Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Long-acting Polypeptide Fatty Acid Side Chain Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Long-acting Polypeptide Fatty Acid Side Chain Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Long-acting Polypeptide Fatty Acid Side Chain Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Long-acting Polypeptide Fatty Acid Side Chain Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)

Table 7. Global Long-acting Polypeptide Fatty Acid Side Chain Sales by Region (2020-2025) & (kg)

Table 8. Global Long-acting Polypeptide Fatty Acid Side Chain Sales by Region (2026-2031) & (kg)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Long-acting Polypeptide Fatty Acid Side Chain Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)

Table 11. Global Long-acting Polypeptide Fatty Acid Side Chain Production by Region (2020-2025) & (kg)

Table 12. Global Long-acting Polypeptide Fatty Acid Side Chain Production by Region (2026-2031) & (kg)

Table 13. Global Long-acting Polypeptide Fatty Acid Side Chain Sales by Manufacturers (2020-2025) & (kg)

Table 14. Global Long-acting Polypeptide Fatty Acid Side Chain Sales Share by Manufacturers (2020-2025)

Table 15. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Long-acting Polypeptide Fatty Acid Side Chain by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Polypeptide Fatty Acid Side Chain as of 2024)

Table 19. Global Long-acting Polypeptide Fatty Acid Side Chain Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Long-acting Polypeptide Fatty Acid Side Chain Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)

Table 21. Key Manufacturers Long-acting Polypeptide Fatty Acid Side Chain Manufacturing Base and Headquarters

Table 22. Global Long-acting Polypeptide Fatty Acid Side Chain Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Long-acting Polypeptide Fatty Acid Side Chain Sales by Type (2020-2025) & (kg)

Table 26. Global Long-acting Polypeptide Fatty Acid Side Chain Sales by Type (2026-2031) & (kg)

Table 27. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Long-acting Polypeptide Fatty Acid Side Chain ASP by Type (2020-2031) & (US$/kg)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Long-acting Polypeptide Fatty Acid Side Chain Sales by Application (2020-2025) & (kg)

Table 32. Global Long-acting Polypeptide Fatty Acid Side Chain Sales by Application (2026-2031) & (kg)

Table 33. Long-acting Polypeptide Fatty Acid Side Chain High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Long-acting Polypeptide Fatty Acid Side Chain ASP by Application (2020-2031) & (US$/kg)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Long-acting Polypeptide Fatty Acid Side Chain Growth Accelerators and Market Barriers

Table 40. North America Long-acting Polypeptide Fatty Acid Side Chain Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Long-acting Polypeptide Fatty Acid Side Chain Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Long-acting Polypeptide Fatty Acid Side Chain Growth Accelerators and Market Barriers

Table 43. Europe Long-acting Polypeptide Fatty Acid Side Chain Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Long-acting Polypeptide Fatty Acid Side Chain Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Growth Accelerators and Market Barriers

Table 48. Southeast Asia Long-acting Polypeptide Fatty Acid Side Chain Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Long-acting Polypeptide Fatty Acid Side Chain Investment Opportunities and Key Challenges

Table 50. Central and South America Long-acting Polypeptide Fatty Acid Side Chain Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Long-acting Polypeptide Fatty Acid Side Chain Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Long-acting Polypeptide Fatty Acid Side Chain Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Pukang Biotechnology Technology Corporation Information

Table 54. Pukang Biotechnology Technology Description and Major Businesses

Table 55. Pukang Biotechnology Technology Product Models, Descriptions and Specifications

Table 56. Pukang Biotechnology Technology Capacity, Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 57. Pukang Biotechnology Technology Sales Value Proportion by Product in 2024

Table 58. Pukang Biotechnology Technology Sales Value Proportion by Application in 2024

Table 59. Pukang Biotechnology Technology Sales Value Proportion by Geographic Area in 2024

Table 60. Pukang Biotechnology Technology Long-acting Polypeptide Fatty Acid Side Chain SWOT Analysis

Table 61. Pukang Biotechnology Technology Recent Developments

Table 62. Changsha Morning Shine Corporation Information

Table 63. Changsha Morning Shine Description and Major Businesses

Table 64. Changsha Morning Shine Product Models, Descriptions and Specifications

Table 65. Changsha Morning Shine Capacity, Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 66. Changsha Morning Shine Sales Value Proportion by Product in 2024

Table 67. Changsha Morning Shine Sales Value Proportion by Application in 2024

Table 68. Changsha Morning Shine Sales Value Proportion by Geographic Area in 2024

Table 69. Changsha Morning Shine Long-acting Polypeptide Fatty Acid Side Chain SWOT Analysis

Table 70. Changsha Morning Shine Recent Developments

Table 71. SINOPEG Corporation Information

Table 72. SINOPEG Description and Major Businesses

Table 73. SINOPEG Product Models, Descriptions and Specifications

Table 74. SINOPEG Capacity, Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 75. SINOPEG Sales Value Proportion by Product in 2024

Table 76. SINOPEG Sales Value Proportion by Application in 2024

Table 77. SINOPEG Sales Value Proportion by Geographic Area in 2024

Table 78. SINOPEG Long-acting Polypeptide Fatty Acid Side Chain SWOT Analysis

Table 79. SINOPEG Recent Developments

Table 80. JenKem Technology Corporation Information

Table 81. JenKem Technology Description and Major Businesses

Table 82. JenKem Technology Product Models, Descriptions and Specifications

Table 83. JenKem Technology Capacity, Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 84. JenKem Technology Sales Value Proportion by Product in 2024

Table 85. JenKem Technology Sales Value Proportion by Application in 2024

Table 86. JenKem Technology Sales Value Proportion by Geographic Area in 2024

Table 87. JenKem Technology Long-acting Polypeptide Fatty Acid Side Chain SWOT Analysis

Table 88. JenKem Technology Recent Developments

Table 89. Sichuan Tongsheng Biopharmaceutical Corporation Information

Table 90. Sichuan Tongsheng Biopharmaceutical Description and Major Businesses

Table 91. Sichuan Tongsheng Biopharmaceutical Product Models, Descriptions and Specifications

Table 92. Sichuan Tongsheng Biopharmaceutical Capacity, Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 93. Sichuan Tongsheng Biopharmaceutical Sales Value Proportion by Product in 2024

Table 94. Sichuan Tongsheng Biopharmaceutical Sales Value Proportion by Application in 2024

Table 95. Sichuan Tongsheng Biopharmaceutical Sales Value Proportion by Geographic Area in 2024

Table 96. Sichuan Tongsheng Biopharmaceutical Long-acting Polypeptide Fatty Acid Side Chain SWOT Analysis

Table 97. Sichuan Tongsheng Biopharmaceutical Recent Developments

Table 98. Key Raw Materials Distribution

Table 99. Raw Materials Key Suppliers

Table 100. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 101. Milestones in Production Technology Evolution

Table 102. Distributors List

Table 103. Market Trends and Market Evolution

Table 104. Market Drivers and Opportunities

Table 105. Market Challenges, Risks, and Restraints

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Long-acting Polypeptide Fatty Acid Side Chain Product Picture

Figure 2. Global Long-acting Polypeptide Fatty Acid Side Chain Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Laboratory Grade Product Picture

Figure 4. GMP Grade Product Picture

Figure 5. Global Long-acting Polypeptide Fatty Acid Side Chain Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Liraglutide

Figure 7. Semaglutide

Figure 8. Telportide

Figure 9. Other

Figure 10. Long-acting Polypeptide Fatty Acid Side Chain Report Years Considered

Figure 11. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 13. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue Market Share by Region (2020-2031)

Figure 15. Global Long-acting Polypeptide Fatty Acid Side Chain Sales (2020-2031) & (kg)

Figure 16. Global Long-acting Polypeptide Fatty Acid Side Chain Sales (CAGR) by Region (2020-2031) (kg)

Figure 17. Global Long-acting Polypeptide Fatty Acid Side Chain Sales Market Share by Region (2020-2031)

Figure 18. Global Long-acting Polypeptide Fatty Acid Side Chain Capacity, Production and Utilization (2020-2031) & (kg)

Figure 19. Global Long-acting Polypeptide Fatty Acid Side Chain Production Trend by Region (2020-2031) (kg)

Figure 20. Global Long-acting Polypeptide Fatty Acid Side Chain Production Market Share by Region (2020-2031)

Figure 21. Production Capacity Enablers & Constraints

Figure 22. Long-acting Polypeptide Fatty Acid Side Chain Production Growth Rate in North America (2020-2031) & (kg)

Figure 23. Long-acting Polypeptide Fatty Acid Side Chain Production Growth Rate in Europe (2020-2031) & (kg)

Figure 24. Long-acting Polypeptide Fatty Acid Side Chain Production Growth Rate in China (2020-2031) & (kg)

Figure 25. Long-acting Polypeptide Fatty Acid Side Chain Production Growth Rate in Japan (2020-2031) & (kg)

Figure 26. Top 5 and Top 10 Manufacturers Long-acting Polypeptide Fatty Acid Side Chain Sales Volume Market Share in 2024

Figure 27. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue Market Share Ranking (2024)

Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 29. Laboratory Grade Revenue Market Share by Manufacturer in 2024

Figure 30. GMP Grade Revenue Market Share by Manufacturer in 2024

Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 33. Global Long-acting Polypeptide Fatty Acid Side Chain Sales Market Share by Type (2020-2031)

Figure 34. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue Market Share by Type (2020-2031)

Figure 35. Global Long-acting Polypeptide Fatty Acid Side Chain Sales Market Share by Application (2020-2031)

Figure 36. Global Long-acting Polypeptide Fatty Acid Side Chain Revenue Market Share by Application (2020-2031)

Figure 37. North America Long-acting Polypeptide Fatty Acid Side Chain Sales YoY (2020-2031) & (kg)

Figure 38. North America Long-acting Polypeptide Fatty Acid Side Chain Revenue YoY (2020-2031) & (US$ Million)

Figure 39. North America Top 5 Manufacturers Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) in 2024

Figure 40. North America Long-acting Polypeptide Fatty Acid Side Chain Sales Volume (kg) by Type (2020- 2031)

Figure 41. North America Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 42. North America Long-acting Polypeptide Fatty Acid Side Chain Sales Volume (kg) by Application (2020-2031)

Figure 43. North America Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) by Application (2020-2031)

Figure 44. US Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 45. Canada Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 46. Mexico Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 47. Europe Long-acting Polypeptide Fatty Acid Side Chain Sales YoY (2020-2031) & (kg)

Figure 48. Europe Long-acting Polypeptide Fatty Acid Side Chain Revenue YoY (2020-2031) & (US$ Million)

Figure 49. Europe Top 5 Manufacturers Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) in 2024

Figure 50. Europe Long-acting Polypeptide Fatty Acid Side Chain Sales Volume (kg) by Type (2020-2031)

Figure 51. Europe Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) by Type (2020-2031)

Figure 52. Europe Long-acting Polypeptide Fatty Acid Side Chain Sales Volume (kg) by Application (2020-2031)

Figure 53. Europe Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) by Application (2020-2031)

Figure 54. Germany Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 55. France Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 56. U.K. Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 57. Italy Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 58. Russia Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 59. Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Sales YoY (2020-2031) & (kg)

Figure 60. Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Revenue YoY (2020-2031) & (US$ Million)

Figure 61. Asia-Pacific Top 8 Manufacturers Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) in 2024

Figure 62. Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Sales Volume (kg) by Type (2020- 2031)

Figure 63. Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 64. Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Sales Volume (kg) by Application (2020-2031)

Figure 65. Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) by Application (2020-2031)

Figure 66. Indonesia Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 67. Japan Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 68. South Korea Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 69. China Taiwan Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 70. India Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2031) & (US$ Million)

Figure 71. Central and South America Long-acting Polypeptide Fatty Acid Side Chain Sales YoY (2020-2031) & (kg)

Figure 72. Central and South America Long-acting Polypeptide Fatty Acid Side Chain Revenue YoY (2020-2031) & (US$ Million)

Figure 73. Central and South America Top 5 Manufacturers Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) in 2024

Figure 74. Central and South America Long-acting Polypeptide Fatty Acid Side Chain Sales Volume (kg) by Type (2021-2031)

Figure 75. Central and South America Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) by Type (2020-2031)

Figure 76. Central and South America Long-acting Polypeptide Fatty Acid Side Chain Sales Volume (kg) by Application (2020-2031)

Figure 77. Central and South America Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) by Application (2020-2031)

Figure 78. Brazil Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2025) & (US$ Million)

Figure 79. Argentina Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2025) & (US$ Million)

Figure 80. Middle East, and Africa Long-acting Polypeptide Fatty Acid Side Chain Sales YoY (2020-2031) & (kg)

Figure 81. Middle East and Africa Long-acting Polypeptide Fatty Acid Side Chain Revenue YoY (2020-2031) & (US$ Million)

Figure 82. Middle East and Africa Top 5 Manufacturers Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) in 2024

Figure 83. Middle East and Africa Long-acting Polypeptide Fatty Acid Side Chain Sales Volume (kg) by Type (2021-2031)

Figure 84. South America Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) by Type (2020-2031)

Figure 85. Middle East and Africa Long-acting Polypeptide Fatty Acid Side Chain Sales Volume (kg) by Application (2020-2031)

Figure 86. Middle East and Africa Long-acting Polypeptide Fatty Acid Side Chain Sales Revenue (US$ Million) by Application (2020-2031)

Figure 87. GCC Countries Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2025) & (US$ Million)

Figure 88. Turkey Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2025) & (US$ Million)

Figure 89. Egypt Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2025) & (US$ Million)

Figure 90. South Africa Long-acting Polypeptide Fatty Acid Side Chain Revenue (2020-2025) & (US$ Million)

Figure 91. Long-acting Polypeptide Fatty Acid Side Chain Industry Chain Mapping

Figure 92. Regional Long-acting Polypeptide Fatty Acid Side Chain Manufacturing Base Distribution (%)

Figure 93. Long-acting Polypeptide Fatty Acid Side Chain Production Process

Figure 94. Regional Long-acting Polypeptide Fatty Acid Side Chain Production Cost Structure

Figure 95. Channels of Distribution (Direct Vs Distribution)

Figure 96. Bottom-up and Top-down Approaches for This Report

Figure 97. Data Triangulation

Figure 98. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Long-acting Polypeptide Fatty Acid Side Chain market? zhanKai

The top companies in the global Long-acting Polypeptide Fatty Acid Side Chain market are Pukang Biotechnology Technology、Changsha Morning Shine、SINOPEG.

Related Reports

Global Long-acting Polypeptide Fatty Acid Side Chain Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Long-acting Polypeptide Fatty Acid Side Chain market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 124
USD 4900.00
(Single User License)
Global Long-acting Polypeptide Fatty Acid Side Chain Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Long-acting Polypeptide Fatty Acid Side Chain market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 66
USD 4250.00
(Single User License)
Long-acting Polypeptide Fatty Acid Side Chain- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Long-acting Polypeptide Fatty Acid Side Chain was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 86
USD 3950.00
(Single User License)
Global Long-acting Polypeptide Fatty Acid Side Chain Market Research Report 2026
The global Long-acting Polypeptide Fatty Acid Side Chain market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 123
USD 2900.00
(Single User License)
Long-acting Polypeptide Fatty Acid Side Chain - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Long-acting Polypeptide Fatty Acid Side Chain was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-13
Pages: 84
USD 3950.00
(Single User License)
Global Long-acting Polypeptide Fatty Acid Side Chain Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Long-acting Polypeptide Fatty Acid Side Chain market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 65
USD 4250.00
(Single User License)
Global Long-acting Polypeptide Fatty Acid Side Chain Market Research Report 2025
The global market for Long-acting Polypeptide Fatty Acid Side Chain was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 82
USD 2900.00
(Single User License)
Global and United States Long-acting Polypeptide Fatty Acid Side Chain Market Report & Forecast 2024-2030
Long-acting polypeptide fatty acid side chains are a technology that extends the half-life of polypeptide molecules in the body by introducing fatty acid side chains into them. By binding to polypeptides, fatty acid side chains can increase their affinity with plasma proteins (such as albumin), reduce renal clearance, and thus prolong the existence time of polypeptides in the blood. This modification technology is widely used in the development of long-acting drugs, such as polypeptide drugs for the treatment of chronic diseases such as diabetes and obesity, to reduce the frequency of medication and improve patient compliance and treatment effects.
Published Date: 2024-08-31
Pages: 82
USD 4350.00
(Single User License)
Global Long-acting Polypeptide Fatty Acid Side Chain Market Research Report 2024
Long-acting polypeptide fatty acid side chains are a technology that extends the half-life of polypeptide molecules in the body by introducing fatty acid side chains into them. By binding to polypeptides, fatty acid side chains can increase their affinity with plasma proteins (such as albumin), reduce renal clearance, and thus prolong the existence time of polypeptides in the blood. This modification technology is widely used in the development of long-acting drugs, such as polypeptide drugs for the treatment of chronic diseases such as diabetes and obesity, to reduce the frequency of medication and improve patient compliance and treatment effects.
Published Date: 2024-08-31
Pages: 84
USD 2900.00
(Single User License)
Global Long-acting Polypeptide Fatty Acid Side Chain Market Insights, Forecast to 2030
Long-acting polypeptide fatty acid side chains are a technology that extends the half-life of polypeptide molecules in the body by introducing fatty acid side chains into them. By binding to polypeptides, fatty acid side chains can increase their affinity with plasma proteins (such as albumin), reduce renal clearance, and thus prolong the existence time of polypeptides in the blood. This modification technology is widely used in the development of long-acting drugs, such as polypeptide drugs for the treatment of chronic diseases such as diabetes and obesity, to reduce the frequency of medication and improve patient compliance and treatment effects.
Published Date: 2024-08-31
Pages: 113
USD 4900.00
(Single User License)

Global Long-acting Polypeptide Fatty Acid Side Chain Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Long-acting Polypeptide Fatty Acid Side Chain market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 124
USD 4900.00 (Single User License)
Global Long-acting Polypeptide Fatty Acid Side Chain Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Long-acting Polypeptide Fatty Acid Side Chain market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 66
USD 4250.00 (Single User License)
Long-acting Polypeptide Fatty Acid Side Chain- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Long-acting Polypeptide Fatty Acid Side Chain was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 86
USD 3950.00 (Single User License)
Global Long-acting Polypeptide Fatty Acid Side Chain Market Research Report 2026
The global Long-acting Polypeptide Fatty Acid Side Chain market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 123
USD 2900.00 (Single User License)
Long-acting Polypeptide Fatty Acid Side Chain - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Long-acting Polypeptide Fatty Acid Side Chain was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-13
Pages: 84
USD 3950.00 (Single User License)
Global Long-acting Polypeptide Fatty Acid Side Chain Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Long-acting Polypeptide Fatty Acid Side Chain market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 65
USD 4250.00 (Single User License)
Global Long-acting Polypeptide Fatty Acid Side Chain Market Research Report 2025
The global market for Long-acting Polypeptide Fatty Acid Side Chain was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 82
USD 2900.00 (Single User License)
Global and United States Long-acting Polypeptide Fatty Acid Side Chain Market Report & Forecast 2024-2030
Long-acting polypeptide fatty acid side chains are a technology that extends the half-life of polypeptide molecules in the body by introducing fatty acid side chains into them. By binding to polypeptides, fatty acid side chains can increase their affinity with plasma proteins (such as albumin), reduce renal clearance, and thus prolong the existence time of polypeptides in the blood. This modification technology is widely used in the development of long-acting drugs, such as polypeptide drugs for the treatment of chronic diseases such as diabetes and obesity, to reduce the frequency of medication and improve patient compliance and treatment effects.
Published: 2024-08-31
Pages: 82
USD 4350.00 (Single User License)
Global Long-acting Polypeptide Fatty Acid Side Chain Market Research Report 2024
Long-acting polypeptide fatty acid side chains are a technology that extends the half-life of polypeptide molecules in the body by introducing fatty acid side chains into them. By binding to polypeptides, fatty acid side chains can increase their affinity with plasma proteins (such as albumin), reduce renal clearance, and thus prolong the existence time of polypeptides in the blood. This modification technology is widely used in the development of long-acting drugs, such as polypeptide drugs for the treatment of chronic diseases such as diabetes and obesity, to reduce the frequency of medication and improve patient compliance and treatment effects.
Published: 2024-08-31
Pages: 84
USD 2900.00 (Single User License)
Global Long-acting Polypeptide Fatty Acid Side Chain Market Insights, Forecast to 2030
Long-acting polypeptide fatty acid side chains are a technology that extends the half-life of polypeptide molecules in the body by introducing fatty acid side chains into them. By binding to polypeptides, fatty acid side chains can increase their affinity with plasma proteins (such as albumin), reduce renal clearance, and thus prolong the existence time of polypeptides in the blood. This modification technology is widely used in the development of long-acting drugs, such as polypeptide drugs for the treatment of chronic diseases such as diabetes and obesity, to reduce the frequency of medication and improve patient compliance and treatment effects.
Published: 2024-08-31
Pages: 113
USD 4900.00 (Single User License)